Cevdet Aydin

Cevdet Aydin

Auto-generated profile, based on publicly available information

Cevdet Aydin

Faculty of Medicine, Endocrinology and Metabolism Diseases Department, Ankara Yıldırım Beyazıt University, Ankara, Turkey

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 April 2023 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
ABAdnan Batman
Adnan Batman
DYDilek Yazıcı
Dilek Yazıcı
ODOğuz Dikbaş
Oğuz Dikbaş
KAKemal Ağbaht
Kemal Ağbaht
ESEmre Sedar Saygılı
Emre Sedar Saygılı
MSMustafa - Sahin
Mustafa - Sahin
Context: The aims of the study are to compare characteristics of subacute thyroiditis (SAT) related to different etiologies, and to identify predictors of recurrence of SAT and incident hypothyroidism. Methods: This nationwide, multicenter, retrospective cohort study included 53 endocrinology centers in Turkey. The study participants were divided into either COVID-19–related SAT (Cov-SAT), SARS-CoV-2 vaccine–related SAT (Vac-SAT), or control SAT (Cont-SAT) groups. Results: Of the 811 patients, 258 (31.8%) were included in the Vac-SAT group, 98 (12.1%) in the Cov-SAT group, and 455 (56.1%) in the Cont-SAT group. No difference was found between the groups with regard to laboratory and imaging findings. SAT etiology was not an independent predictor of recurrence or hypothyroidism. In the entire cohort, steroid therapy requirement and younger age were statistically significant predictors for SAT recurrence. C-reactive protein measured during SAT onset, female sex, absence of antithyroid peroxidase (TPO) positivity, and absence of steroid therapy were statistically significant predictors of incident (early) hypothyroidism, irrespective of SAT etiology. On the other hand, probable predictors of established hypothyroidism differed from that of incident hypothyroidism. Conclusion: Since there is no difference in terms of follow-up parameters and outcomes, COVID-19– and SARS-CoV-2 vaccine–related SAT can be treated and followed up like classic SATs. Recurrence was determined by younger age and steroid therapy requirement. Steroid therapy independently predicts incident hypothyroidism that may sometimes be transient in overall SAT and is also associated with a lower risk of established hypothyroidism.

10 July 2024 in Endocrine
Verified
Journal Article
Open access
PDF file
FKFatma Dilek Dellal Kahramanca
Fatma Dilek Dellal Kahramanca
MSMuhammet Sacikara
Muhammet Sacikara
AKAydan Kilicarslan
Aydan Kilicarslan
BOBerna Ogmen
Berna Ogmen
CACevdet Aydin
Cevdet Aydin
BCBekir Cakir
Bekir Cakir
Purpose: To determine whether early repeat fine needle aspiration biopsy (FNA) has an effect on adequate or atypia of undetermined significance (AUS) cytology rates in thyroid nodules with inadequate or AUS result in the first FNA. Methods: Nodules of patients who underwent repeat biopsy due to insufficient or AUS cytology between 2019–2022 were included. Data of the patients and ultrasonographic, cytological and histopathological results of the nodules were recorded. Additionally, the time between the two biopsies was noted. The first was called “initial” and the second was called “rebiopsy”. Five different paired groups were formed according to the time between two consecutive biopsies; before and after 1 month, 45 days, 2 months, 3 months, and 6 months. The groups were compared in terms of adequate and AUS cytological results. Results: We evaluated 1129 patients with 2187 nodules undergoing FNAB. After excluding nodules with one FNA result and/or missing data, 966 nodules of 628 patients who underwent FNA at least twice were included. Initial cytology was nondiagnostic (ND) in 665 (30.4%) and AUS in 301 (13.8%) nodules. The mean age of the patients was 52.0 ± 11.9 years, and the female sex ratio was 78.8% (n = 495). There were no differences in adequate or AUS rebiopsy results according to the different time interval groups (p > 0.05 for all). AUS result was statistically insignificantly more frequent in nodules with initially AUS nodules when rebiopsy was performed before 1 month in comparison to after 1 month (53.8%, 27.1%; p = 0.054). Accuracy of rebiopsy was also similar in the time intervals groups (p > 0.05 for all). Conclusion: In patients with inadequate or AUS initial biopsy, the rate of adequate or AUS cytology results at rebiopsy did not vary with the timing of repeat biopsy indicating that there may be no need to wait 1 month for a repeat biopsy. In patients with suspicious nodules, biopsy might be repeated before 1 month.

19 May 2025 in Postgraduate Medicine
Verified
Journal Article
Closed access
EKEkin Yiğit Köroğlu
Ekin Yiğit Köroğlu
BÖBerna Evranos Öğmen
Berna Evranos Öğmen
BBBELMA OZLEM TURAL BALSAK
BELMA OZLEM TURAL BALSAK
MYMustafa Ömer Yazicioğlu
Mustafa Ömer Yazicioğlu
CACevdet Aydin
Cevdet Aydin
BÇBekir Çakir
Bekir Çakir
Accurate tumor localization is necessary for the application of minimally invasive surgery, which is preferred in the treatment of primary hyperparathyroidism. Parathormone-washout (PTH-WO) is parathyroid fine-needle aspiration followed by PTH measurement in the needle washout fluid. This study aimed to determine appropriate cutoff values for the PTH-WO method. A total of 402 PTH-WO assays from 339 patients were included in the study. The diagnostic accuracy of the test was assessed by accepting as a positive result a PTH-WO result higher than the serum PTH level [PTH-WO/serum PTH(PTH ratio)>1]. In addition, a cutoff value for the test was established by evaluating the PTH washout results obtained in comparison with postoperative histopathology. Undiluted test results were not included to obtain a clear numerical value in this evaluation. The results of parathyroid scintigraphy and fine needle aspiration biopsy (FNAB) were compared with postoperative histopathology. While 309 (76.86%) of the PTH-WO procedures were considered positive, 93 (23.13%) were considered negative if the PTH ratio was > 1. When these results were compared with the postoperative histopathology, the test's sensitivity was 92.51%, and the specificity was 100.00%. In the analysis of the remaining 292 PTH-WO samples after excluding the undiluted ones, the sensitivity and specificity of the method were 92.3% and 94.1%, respectively, with a PTH ratio > 0.99. With a cutoff value of 99.5 ng/l for PTH-WO value, 93.1% sensitivity and 94.3% specificity were obtained. The sensitivities of parathyroid scintigraphy and FNAB were 53.4% and 15.3%, respectively. The PTH-WO method is safe and cheap, with high sensitivity and specificity in localizing parathyroid tumor. In cases where radiological methods cannot achieve localization with specified cutoff values, it has high diagnostic accuracy.

1 May 2024 in Minerva Urology and Nephrology
Verified
Journal Article
Closed access
AOAli Y. Ozercan
Ali Y. Ozercan
OGOzer Guzel
Ozer Guzel
NINarin N. Imga
Narin N. Imga
OTOya Topaloglu
Oya Topaloglu
CACevdet Aydin
Cevdet Aydin
ATAltug Tuncel
Altug Tuncel
Article: Fluorescence-guided laparoscopic partial adrenalectomy in adrenal medullary hyperplasia mimicking pheochromocytoma - Minerva Urology and Nephrology 2023 Nov 21 - Minerva Medica - Journals


25 May 2026 in BMC Cancer
Verified
Journal Article
Open access
PDF file
EKEkin Yiğit Köroğlu
Ekin Yiğit Köroğlu
BÖBerna Evranos Öğmen
Berna Evranos Öğmen
MDMuzaffer Serdar Deniz
Muzaffer Serdar Deniz
BSBarış Saylam
Barış Saylam
HAHilal Ahsen
Hilal Ahsen
BÇBekir Çakir
Bekir Çakir
Medullary thyroid carcinoma (MTC) treatment guidelines recommend surgical extent based primarily on calcitonin levels, yet the oncologic impact of deviatin